Kit for Drug-Containing Nanoparticles and Composition for Drug Delivery
Summary
The USPTO has published a new patent application (US20260083682A1) by SAMYANG HOLDINGS CORPORATION for a kit and composition for constructing drug-containing nanoparticles for enhanced drug delivery. The application details a method utilizing cationic compounds and anionic polymers to improve cellular drug delivery efficiency.
What changed
This document is a published patent application (US20260083682A1) from the USPTO, filed by SAMYANG HOLDINGS CORPORATION. It describes a kit and nanoparticle composition designed to improve the efficiency of cellular drug delivery. The invention utilizes nanoparticles incorporating a cationic compound and an anionic polymer compound with at least one acidic functional group to achieve this enhanced delivery.
As this is a patent application, it does not impose immediate regulatory obligations or compliance deadlines on regulated entities. However, it represents a new development in drug delivery technology that pharmaceutical companies and medical device makers may wish to monitor for potential future licensing or competitive landscape analysis. The filing date was July 26, 2023.
Archived snapshot
Mar 26, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
KIT FOR MANUFACTURE OF DRUG-CONTAINING NANOPARTICLES AND NANOPARTICLE COMPOSITION FOR DRUG DELIVERY
Application US20260083682A1 Kind: A1 Mar 26, 2026
Assignee
SAMYANG HOLDINGS CORPORATION
Inventors
Go Eun Kim, Kyu Jin KYUNG, So Young KIM, Joung Pyo NAM, So Jin LEE, Jong Min PARK, Won II SEO
Abstract
The present invention relates to a kit for construction of drug-containing nanoparticles and a nanoparticle composition for drug delivery. More specifically, the present invention concerns a kit for construction of drug-containing nanoparticles and a nanoparticle composition for drug delivery, each designed to increase the efficiency of cellular drug delivery by utilizing nanoparticles that include a cationic compound and an anionic polymer compound with at least one acidic functional group.
CPC Classifications
A61K 9/5153 A61K 31/7105
Filing Date
2023-07-26
Application No.
19109662
Related changes
Get daily alerts for USPTO Patent Applications - Pharma (A61K)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Applications - Pharma (A61K) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.